Structural Entry Filters:

Search Count: 75

Download
9DKO image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1010 (6-Cyclopropyl-2,4-Dimethyl-3-(4-(Trifluoromethyl)Benzyl)-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)

9DI6 image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm679 (Ethyl 1,4-Dimethyl-5-((6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-1H-Pyrazole-3-Carboxylate)

9DIK image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm681 (N-Cyclopropyl-1,4-Dimethyl-5-((6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-1H-Pyrazole-3-Carboxamide)

9DIZ image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm959 (6-Cyclopropyl-2,4-Dimethyl-3-((6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)

9DKQ image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1153 (4,6-Dicyclopropyl-3-(3-Fluoro-4-(Trifluoromethyl)Benzyl)-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-D]Pyridazin-7-One)

9DKY image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1174 (3-((7-Azaspiro[3.5]Nonan-7-Yl)Methyl)-4-Cyclopropyl-6-Ethyl-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)

9DLK image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1398 ((S)-3-(Amino(3-Chloro-4-(Trifluoromethyl)Phenyl)(Cyclopropyl)Methyl)-6-Cyclopropyl-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-D]Pyridazin-7-One)

9DLY image
Crystal Structure Of Plasmodium Falciparum Dihydroorotate Dehydrogenase Bound With Inhibitor Dsm1211 ((R)-3-(Amino(6-(Trifluoromethyl)Pyridin-3-Yl)Methyl)-4-Cyclopropyl-6-Ethyl-2-Methyl-2,6-Dihydro-7H-Pyrazolo[3,4-C]Pyridin-7-One)

6X3R image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors

6X3Y image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors

6X4M image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors: Tert-Butyl [(2S)-1-{[(3S,17S)-2,16-Dioxo-10,15-Dioxa-1,21-Diazatricyclo[15.3.1.1~5,9~]Docosa-5(22),6,8-Trien-3-Yl]Amino}-3-Methyl-1-Oxobutan-2-Yl]Carbamate (Compound 3)

6X4N image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors: (2R,5S,11S,14S,18E)-2,11,17,17-Tetramethyl-14-(Propan-2-Yl)-3-Oxa-9,12,15,26,29-Pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]Nonacosa-1(25),18,20(28),21,23,26-Hexaene-4,10,13,16-Tetrone (Compound 24)

6X4O image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors: (2R,5S,11S,14S,18E)-2,11-Dimethyl-14-(Propan-2-Yl)-3-Oxa-9,12,15,21,29-Pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]Nonacosa-1(26),18,20,22,24,27-Hexaene-4,10,13,16-Tetrone (Compound 21)

6X4P image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors: (2R,5S,11S,14S,18E)-2,11,17,17-Tetramethyl-14-(Propan-2-Yl)-15-Oxa-3,9,12,26,29-Pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]Nonacosa-1(25),18,20(28),21,23,26-Hexaene-4,10,13,16-Tetrone (Compound 28)

6X4Q image
Human Cyclophilin A Bound To A Series Of Acylcic And Macrocyclic Inhibitors: (2R,5S,11S,14S,18E)-14-Cyclobutyl-2,11,17,17-Tetramethyl-15-Oxa-3,9,12,26,29-Pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]Nonacosa-1(25),18,20(28),21,23,26-Hexaene-4,10,13,16-Tetrone (Compound 33)

4U6Q image
Ctbp1 Bound To Inhibitor 2-(Hydroxyimino)-3-Phenylpropanoic Acid

4U6S image
Ctbp1 In Complex With Substrate Phenylpyruvate

4HOE image
Candida Albicans Dihydrofolate Reductase Complexed With Nadph And 5-[3-(2,5-Dimethoxy-4-Phenylphenyl)But-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine (Ucp111E)

4HOF image
Candida Albicans Dihydrofolate Reductase Complexed With Nadph And 5-[3-(2-Methoxy-4-Phenylphenyl)But-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine (Ucp111H)

4HOG image
Candida Glabrata Dihydrofolate Reductase Complexed With Nadph And 5-[3-(2-Methoxy-4-Phenylphenyl)But-1-Yn-1-Yl]-6-Methylpyrimidine-2,4-Diamine (Ucp111H)
Protein Functional Filters:
Feedback Form
Name
Email
Institute
Feedback